Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell/histiocyte-rich B cell lymphoma

Annals of Oncology

Volumn 13, Issue SUPPL. 1, 2002, Pages 44-51

  Wiedenmann, S ^a   Rudiger T ^b   Gascoyne, R D ^c   Muller Hermelink H K ^b   Jaffe, E S ^d   De Jong, D ^e   Delabie, J ^f   De Wolf Peeters, C ^g   Poppema, S ^h   Xerri, L ⁱ   Gisselbrecht, C ^j  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e NETHERLANDS CANCER INSTITUTE   (Netherlands)

^f OSLO UNIVERSITY HOSPITAL   (Norway)

^g UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^h UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

ⁱ INSTITUT PAOLI CALMETTES   (France)

^j SAINT LOUIS HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DNA; IMMUNOGLOBULIN D; TRANSCRIPTION FACTOR PU 1; IMMUNOGLOBULIN;

ARTICLE; B CELL LYMPHOMA; BELGIUM; CANCER CLASSIFICATION; CANCER RESEARCH; COMPARATIVE GENOMIC HYBRIDIZATION; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE MARKER; DNA DETERMINATION; HISTIOCYTE; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; NETHERLANDS; NONHODGKIN LYMPHOMA; NORWAY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REED STERNBERG CELL; T CELL LYMPHOMA; TUMOR BIOPSY; WORKSHOP; ADULT; AGED; CLINICAL TRIAL; FEMALE; HISTIOCYTIC LYMPHOMA; LYMPH NODE; MALE; MIDDLE AGED; PATHOLOGY; REVIEW; TREATMENT OUTCOME;

ADULT; AGED; CLINICAL TRIALS; FEMALE; HODGKIN DISEASE; HUMANS; IMMUNOGLOBULINS; IMMUNOPHENOTYPING; LYMPH NODES; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL; LYMPHOMA, NON-HODGKIN; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 34547999274     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdf071     Document Type: Article

References (23)

1. T-cell-rich B-cell lymphoma
2. Large B-cell lymphoma rich in T-cells and simulating Hodgkin's disease
3. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype
4. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: Report from the European Task Force on Lymphoma Hodgkin's Disease
5. European Task Force on Lymphoma Project on Lymphocyte Predominance Hodgkin's Disease: Histological and immunohistological analysis of submitted cases reveals two types of Hodgkin's disease with a nodular lymphocytes
6. Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells
7. Workshop report on Hodgkin's disease and related diseases ('grey zone' lymphoma)
8. Molecular analysis of single B cells from T-cell-rich B-cell lymphoma shows the derivation of the tumor cells from mutating germinal center B cells and exemplifies means by which immunoglobulin genes are modified in B cells
9. Pathological findings in human autoimmune lymphoproliferative syndrome
10. The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis
11. Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence
12. Non-Hodgkin's lymphoma arising in patients treated for Hodgkin's disease in the BNLI: A 20-year experience
13. Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: Incidence, treatment, and prognosis
14. Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood
15. T-cell rich B-cell non-Hodgkin's lymphoma: A progressed form of follicle centre cell lymphoma and lymphocyte predominance Hodgkin's disease
16. Elderly patients with non-Hodgkin's lymphoma: Population-based results in The Netherlands
17. T-cell-rich B large-cell lymphoma simulating lymphocyte-rich Hodgkin's disease
18. The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease
19. Lymphocyte predominance Hodgkin's disease is characterized by recurrent genomic imbalances
20. T cell/histiocyte rich large B cell lymphoma: A distinct diffuse large B cell lymphoma subtype showing characteristic morphologic and immunophenotypic features
21. T cell/histiocyte rich large B cell lymphoma. A distinct clinicopathological entity
22. Pathologic and clinical features of 77 Hodgkin's lymphoma patients treated in a lymphoma protocol (LNH87): A GELA study